Chronic kidney disease progression among patients with type 2 diabetes identified in US administrative claims: a population cohort study
Csaba P. Kövesdy(University of Tennessee Health Science Center), Kerstin Folkerts(Bayer (Germany)), Natalia Petruski‐Ivleva(AVEO Oncology (United States)), Linda F. Fried(VA Pittsburgh Healthcare System), Alain Gay(Bayer (Germany)), Michael Blankenburg(Bayer (Germany)), Priscilla Velentgas(Aetion (United States)), Danielle L. Isaman(Aetion (United States))
Cited by 22
Related Papers
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
|American Journal of Nephrology|2017|2.2k
Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits
|Nature Genetics|2018|1.5k
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
|JAMA|2014|982
Development and Validation of the American Heart Association’s PREVENT Equations
|Circulation|2023|935
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886